69 results
DRSLTR
TAK
Takeda Pharmaceutical Co
16 Nov 18
Correspondence regarding draft registration statement
12:00am
of the hedging instrument of 3,381 million JPY as an increase to goodwill at the acquisition date. Confirm whether this forward exchange contract was entered … of the hedging instrument, the Company has not relied on the guidance of paragraph 12 of IFRS 3 as the derivative instrument was not a transaction
CORRESP
TAK
Takeda Pharmaceutical Co
6 Dec 18
Correspondence with SEC
12:00am
of the hedging instrument of 3,381 million JPY as an increase to goodwill at the acquisition date. Confirm whether this forward exchange contract was entered … of the hedging instrument, the Company has not relied on the guidance of paragraph 12 of IFRS 3 as the derivative instrument was not a transaction
20FR12B
EX-99.1
TAK
Takeda Pharmaceutical Co
6 Dec 18
Initial registration of securities (foreign private issuers)
10:39am
on revaluation of available-for-sale financial assets
Cash flow hedges
Hedging cost
Share of other comprehensive income (loss) of investments accounted …
on
revaluation of
available-for-
sale financial
assets
Cash flow
hedges
Hedging cost
Re-
measurement
gain or loss
on defined
benefit plans
Total
Other
20FR12B/A
EX-99.1
TAK
Takeda Pharmaceutical Co
17 Dec 18
Initial registration of securities (foreign private issuers) (amended)
6:14am
on revaluation of available-for-sale financial assets
Cash flow hedges
Hedging cost
Share of other comprehensive income (loss) of investments accounted …
on
revaluation of
available-for-
sale financial
assets
Cash flow
hedges
Hedging cost
Re-
measurement
gain or loss
on defined
benefit plans
Total
Other
DRS/A
EX-99.1
TAK
Takeda Pharmaceutical Co
16 Nov 18
Draft registration statement (amended)
12:00am
ofavailable-for-sale financial assets
Cash flow hedges
Hedging cost
Share of other comprehensive income (loss) of investments accounted for using the equity … flow
hedges
Hedging cost
Re-
measurement
gain or loss
on defined
benefit plans
Total
Other
comprehensive
income
related to
assets held
for sale
Total
6-K
EX-99.1
1fnprf7mh298 72fv3
30 May 23
Current report (foreign)
6:14am
6-K
EX-99.1
kixx57
28 May 21
Current report (foreign)
6:03am
6-K
tsz383
27 May 20
Current report (foreign)
6:05am
6-K
EX-99.1
v09nwh4 bpygvvt43
31 May 22
Current report (foreign)
12:00am
424B3
q7jyf flkywscl
14 Nov 19
Prospectus supplement
6:10am
20-F
g0u3y4qr pv0q230mj
27 Jun 19
Annual report (foreign)
6:41am
F-4/A
a27u9 2lz
12 Nov 19
Registration of securities (foreign) (amended)
9:50am
F-4
gwwpg 3hvbnn0xhwxgz
9 Aug 19
Registration of securities (foreign)
6:27am
6-K
dkl7ezn
27 Jul 23
Current report (foreign)
6:05am
6-K
262u9g
26 Oct 23
Current report (foreign)
6:20am
6-K
tbot6
1 Feb 24
Current report (foreign)
6:06am